Trial intelligence / Profile preview

Luteal phase ovarian stimulation in women with poor ovarian response

ChiCTR-OPC-15005883Phase 4Recruiting

Sponsor
Linyi People's Hospital
Start
Jan 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of letrozole and human menopausal gonadotrophin in infertility and poor ovarian response (POR) (3 arms), sponsored by Linyi People's Hospital. Primary endpoints: oocytes aspirated, embryos cryopreserved and 2 more. Started Jan 2013; status: recruiting.

02

Drugs

letrozolehuman menopausal gonadotrophin
03

Conditions

infertilitypoor ovarian response (POR)

Beyond the preview

Go deeper on ChiCTR-OPC-15005883.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPC-15005883.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call